BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23694824)

  • 1. Current concepts on cutaneous MALT lymphomas.
    Fernandez-Flores A
    Am J Dermatopathol; 2013 Jun; 35(4):477-84. PubMed ID: 23694824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.
    Magro CM; Yang A; Fraga G
    Am J Dermatopathol; 2013 May; 35(3):319-26. PubMed ID: 23190506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous MALT-lymphoma: from cutaneous immunocytoma and pseudolymphoma to the current (and future) conceptions.
    Fernandez-Flores A
    Rom J Morphol Embryol; 2013; 54(1):7-12. PubMed ID: 23529303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metachronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) and peripheral T-cell lymphoma unspecified: histologic, immunophenotypic, and molecular documentation.
    Venizelos J; Papadopoulos N; Lambropoulou M; Nikolaidou S; Bolioti S; Tamiolakis D
    Onkologie; 2005 Aug; 28(8-9):423-6. PubMed ID: 16160405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
    Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas.
    Falini B; Agostinelli C; Bigerna B; Pucciarini A; Pacini R; Tabarrini A; Falcinelli F; Piccioli M; Paulli M; Gambacorta M; Ponzoni M; Tiacci E; Ascani S; Martelli MP; Dalla Favera R; Stein H; Pileri SA
    Histopathology; 2012 Nov; 61(5):930-41. PubMed ID: 22716304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Management of Cutaneous B-cell Lymphoma.
    Pinter-Brown LC
    Dermatol Clin; 2015 Oct; 33(4):835-40. PubMed ID: 26433853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
    Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
    J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: A crucial role and a new lymphoma paradigm.
    Kempf W; Kerl H; Kutzner H
    Am J Dermatopathol; 2010 Apr; 32(2):194-6. PubMed ID: 19940749
    [No Abstract]   [Full Text] [Related]  

  • 10. Is it possible to overcome antiapoptotic API2/MALT1 events in tumor B-cells by influencing Tregs in MALT lymphoma?
    Dotlic S; Gasparov S; Lovric E; Dominis M; Korac P
    Med Hypotheses; 2012 Oct; 79(4):500-3. PubMed ID: 22832211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous marginal zone B-cell lymphoma of MALT type in a child.
    Dargent JL; Devalck C; De Mey A; Vandeweyer E; Lespagnard L; Heimann P
    Pediatr Dev Pathol; 2006; 9(6):468-73. PubMed ID: 17163787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals.
    Jaffe ES
    Mod Pathol; 2020 Jan; 33(Suppl 1):96-106. PubMed ID: 31653979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets.
    Edinger JT; Kant JA; Swerdlow SH
    Am J Surg Pathol; 2010 Dec; 34(12):1830-41. PubMed ID: 21107089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marginal zone lymphomas.
    Zucca E; Bertoni F; Stathis A; Cavalli F
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):883-901, viii. PubMed ID: 18954742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
    Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
    Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal zone lymphoma with a dual cutaneous and leukemic presentation and an aberrant myeloid-monocytic phenotype.
    Keehn CA; Cualing H
    J Cutan Pathol; 2006 Mar; 33(3):236-41. PubMed ID: 16466512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
    Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
    J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous marginal zone B-cell lymphomas: are they different from other extranodal marginal zone B-cell lymphomas?
    Ferenczi K
    J Cutan Pathol; 2009 Jun; 36(6):715-7. PubMed ID: 19515055
    [No Abstract]   [Full Text] [Related]  

  • 19. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
    Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
    Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.
    Geyer JT; Ferry JA; Longtine JA; Flotte TJ; Harris NL; Zukerberg LR
    Am J Clin Pathol; 2010 Jan; 133(1):59-69. PubMed ID: 20023259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.